Trial intelligence / Profile preview

Open-label, non-randomised dose escalation study of KRN951 in solid tumors

jRCT2080220823Phase 1

Sponsor

Kyowa Kirin

Start

Aug 2009

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1